- Home
- KAR vs DNLI Comparison
KAR vs DNLI Comparison
Compare KAR & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAR
- DNLI
- Stock Information
- Founded
- KAR 2006
- DNLI 2013
- Country
- KAR United States
- DNLI United States
- Employees
- KAR N/A
- DNLI N/A
- Industry
- KAR Retail-Auto Dealers and Gas Stations
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KAR Consumer Discretionary
- DNLI Health Care
- Exchange
- KAR Nasdaq
- DNLI Nasdaq
- Market Cap
- KAR 2.8B
- DNLI 2.5B
- IPO Year
- KAR 2009
- DNLI 2017
- Fundamental
- Price
- KAR $25.23
- DNLI $19.52
- Analyst Decision
- KAR Buy
- DNLI Strong Buy
- Analyst Count
- KAR 6
- DNLI 13
- Target Price
- KAR $28.50
- DNLI $32.64
- AVG Volume (30 Days)
- KAR 1.1M
- DNLI 1.4M
- Earning Date
- KAR 11-05-2025
- DNLI 11-06-2025
- Dividend Yield
- KAR N/A
- DNLI N/A
- EPS Growth
- KAR 357.93
- DNLI N/A
- EPS
- KAR 0.87
- DNLI N/A
- Revenue
- KAR $1,895,200,000.00
- DNLI N/A
- Revenue This Year
- KAR $5.00
- DNLI N/A
- Revenue Next Year
- KAR $4.79
- DNLI $94,232.03
- P/E Ratio
- KAR $28.84
- DNLI N/A
- Revenue Growth
- KAR 6.75
- DNLI N/A
- 52 Week Low
- KAR $17.08
- DNLI $10.57
- 52 Week High
- KAR $30.93
- DNLI $26.18
- Technical
- Relative Strength Index (RSI)
- KAR 44.19
- DNLI 71.41
- Support Level
- KAR $24.32
- DNLI $16.85
- Resistance Level
- KAR $25.44
- DNLI $19.63
- Average True Range (ATR)
- KAR 0.58
- DNLI 1.17
- MACD
- KAR 0.04
- DNLI 0.27
- Stochastic Oscillator
- KAR 61.90
- DNLI 97.62
About KAR OPENLANE Inc.
Openlane Inc provides a digital marketplace for used vehicles, connecting sellers and buyers in North America and Europe for fast and transparent transactions. Its services include financing, repossessions, repairs, transportation, warranty, and inventory management. The company operates used-vehicle auctions and has two main segments: Marketplace and Finance, with majority revenue coming from the Marketplace segment, which to used vehicle remarketing, including marketplace services, remarketing, or make ready services and all are interrelated, synergistic elements along the auto remarketing chain. The Finance segment, through AFC engaged in business of providing short-term, inventory-secured financing to independent vehicle dealers.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.